Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

A preparation method of argatroban intermediates

A technology for argatroban and intermediates, which is applied in the field of preparing argatroban intermediates, can solve the problems of unsuitability for industrial production, many reaction by-products, and difficult separation, and achieve complete reaction, simple operation, and easy purification Effect

Active Publication Date: 2009-03-04
TIANJIN WEIJIE TECH
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] When L-arginine is directly condensed with quinolinesulfonyl chloride, there are many reaction by-products, which are not easy to separate, and are not suitable for industrial production [Patent Bulletin Ping 1-35000]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A preparation method of argatroban intermediates
  • A preparation method of argatroban intermediates
  • A preparation method of argatroban intermediates

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1.N G - Preparation of nitro-L-arginine

[0030] Add 165 g of concentrated sulfuric acid into a 300 ml four-necked reaction flask, add 34.8 g (0.2 mol) of L-arginine with stirring, stir until transparent, add 20.0 g (0.4 mol) of ammonium nitrate, and stir at room temperature for 3 hours. After the reaction, the reaction solution was poured into 600 grams of ice water, neutralized with about 370 grams of ammonia (17%), controlled to pH 6.5, and a white solid was precipitated, filtered, washed with water, and recrystallized with 900 grams of water to obtain N G -Nitro-L-arginine 35.7 grams, content 98.5% (HPLC quantitative analysis method), yield 80.3%.

Embodiment 2

[0031] Example 2.N G —Nitro—N 2 - Preparation of tBoc-L-arginine

[0032] Add 100ml of water into a 300ml four-necked reaction flask, add 4.4 grams (1.1mol) of sodium hydroxide under stirring, cool after stirring and dissolving, add 20.0 grams (0.091mol) of NG -Nitro-L-arginine and 52 grams of tert-butanol, stirred for a while to obtain a transparent solution, added 25.9 grams (0.119mol) of di-tert-butyl carbonate at a liquid temperatureG —Nitro—N 2 —tBoc—L—arginine (HPLC quantitative analysis method), content 96.5%, yield 57.8%.

Embodiment 3

[0033] Embodiment 3.(2R, 4R)-1-[N G —Nitro—N 2 -(tert-butyloxycarbonyl)-L-arginine]-4-methyl-2-piperidinecarboxylate ethyl ester

[0034] In a 5000ml four-necked reaction flask, add 3000ml of dichloromethane, under stirring, add 112.8g (0.655mol) of (2R,4R)-4-methyl-2-piperidinecarboxylate ethyl ester, and dissolve it in about 0.5 hours. Under stirring at room temperature, add DCC134.8 g (0.655 mol), continue stirring for 0.5 hours, add N G —Nitro—N 2 —tBoc—L—209.0 g (0.655 mol) of arginine, stirred at room temperature for 2 hours, detected by TLC (solvent system is ethyl acetate), the raw materials basically disappeared, and the reaction ended. Add 600ml of water, stir for 0.5 hours, cool the reaction solution to 0°C, filter to remove the by-product urea, separate the filtrate, remove the water layer, wash the organic layer twice with 950ml of 10% sodium hydroxide solution, wash with 600ml of 10% citric acid The solution was washed to neutrality, then washed with 600 ml o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparing method of Argatroban intermediate, which is characterized by the following: adopting NG-nitro-N2-tBoc -L-arginine and (2R,4R)-4-methyl-2-piperidine ethyl formate to condensate; making DCC as dehydrant; reacting under -5-35deg.c for 1-5h and stirring; cooling reacting liquid; filtering to remove solid; stratifying filtrate; removing water layer; washing organic layer through sodium hydroxide solution, citrate solution and saturated salt water; drying; evaporating dichloromethane; obtaining yellow solid product.

Description

technical field [0001] The invention relates to a method for preparing an argatroban intermediate. technical background: [0002] In 1978, S.Okamoto of Mitsubishi Chemical Company in Japan reported for the first time the antithrombin activity of Argatroban (Argatroban)-hydrate [US 4 101 653]. During the following 20 years, many researchers conducted in-depth research on the biological activity of Argatroban and its value as medicine. In 1981, S.Okamoto compared heparin in animals [Okamoto, S.et al., Biochem.Biophys.Res.Commun.101, 440 (1981)]; T.Kumoto et al. reported its stereoselective activity [ Kumada, T.et al., Thromb.Res.24,285(1981)]; 1984, R.Kumato performed clinical hemodialysis evaluation [Kikumoto, R.et al., Biochemistry 23,85(1984)]; 1986 The author reported that Argatroban inhibits thrombin activity in mammals and can be used as a therapeutic and prophylactic agent for thrombosis and an inhibitor of platelet aggregation. The monohydrate of Argatroban can be u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D211/60
Inventor 宋洪海
Owner TIANJIN WEIJIE TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products